Synendos Therapeutics
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $26M
Investors
- 9
About Synendos Therapeutics
Founded in 2019 in Switzerland, Synendos Therapeutics AG is dedicated to developing treatments for neuropsychiatric disorders.000 mn on April 20, 2021, with investments from Ysios Capital Partners.Synendos Therapeutics specializes in creating innovative therapies for neuropsychiatric disorders by modulating the endocannabinoid system. The lead product, SYT-510, classified as a Selective Endocannabinoid Re-uptake Inhibitor (SERI), aims to restore natural brain function affected by endocannabinoid deficiencies linked to conditions such as anxiety and PTSD. The company collaborates with various pharmaceutical stakeholders to facilitate product development. Revenue generation will involve agreements related to clinical trials, drug development partnerships, and potential licensing of proprietary products. The company aims to enhance its proof-of-concept research, and as SYT-510 progresses through clinical trials, it will prepare for market entry strategies. Specific geographic markets for expansion have not been disclosed, but the focus remains on ensuring access to its therapies for those affected by neuropsychiatric conditions.
Who invested in Synendos Therapeutics
9 investors across 2 rounds
See all investors in Synendos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synendos Therapeutics
Who invested in Synendos Therapeutics?
Synendos Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synendos Therapeutics raised?
Synendos Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Synendos Therapeutics last raise money?
Synendos Therapeutics's most recent round on record is a Series A, in Apr 2021.
What does Synendos Therapeutics do?
Founded in 2019 in Switzerland, Synendos Therapeutics AG is dedicated to developing treatments for neuropsychiatric disorders.
Where is Synendos Therapeutics headquartered?
Synendos Therapeutics is headquartered in Switzerland.
Which VCs invest in companies like Synendos Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Synendos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Synendos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.